Borviz 2mg Injection, Composition : Bortezomib

Borviz 2mg Injection (Bortezomib)Product Description

Borviz 2mg Injection contains Bortezomib, a targeted anticancer medicine belonging to the class of proteasome inhibitors. It is primarily used in the treatment of multiple myeloma and mantle cell lymphoma. Bortezomib works by blocking the action of proteasomes inside cancer cells, leading to cancer cell death and slowing disease progression.

Borviz 2mg is administered under the supervision of an oncologist in hospital or cancer care settings, either as an intravenous (IV) injection or subcutaneous (SC) injection.

Key Features & Benefits

• Contains Bortezomib 2mg per vial
• Effective in treating multiple myeloma & mantle cell lymphoma
• Proteasome inhibitor that targets cancer cells
• Can be used as monotherapy or in combination chemotherapy
• Trusted in oncology practice worldwide

Indications

• Multiple Myeloma
• Mantle Cell Lymphoma

Dosage & Administration

• Administered by IV or SC injection
• Dosage depends on patient’s body condition and treatment cycle
• Must be given only under specialist supervision

Storage Instructions

• Store below 25°C in a dry place
• Protect from light and moisture
• Keep out of reach of children

Packaging

• Vial containing Borviz 2mg Injection (Bortezomib)

Why Buy Borviz 2mg Injection Online From Melizza Lifescience?

• 100% authentic & quality-assured oncology injection
• Competitive Borviz 2mg price for bulk & retail supply
• Worldwide shipping with secure packaging
• Trusted exporter of life-saving cancer medicines

Disclaimer

Borviz Injection (Bortezomib) is a prescription-only chemotherapy medicine. It should be used strictly under the supervision of a qualified oncologist.